• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Bridges reaps 2.5x return on sale of Wholebake to Elysian

  • Greg Gille
  • Greg Gille
  • @unquotenews
  • 04 August 2021
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Elysian Capital has acquired UK-based healthy snacks producer Wholebake from Bridges Fund Management.

Wholebake's management will also reinvest in the business. Working capital facilities were provided by Barclays Bank.

In late 2019, Mergermarket reported that Wholebake had hired KPMG to explore a sale, citing two sources familiar with the matter. The process was expected to kick off in 2020.

Wholebake

  • DEAL:

    SBO

  • VALUE:

    n/d (GBP 50m-100m est)

  • LOCATION:

    Chester

  • SECTOR:

    Food products

  • FOUNDED:

    1984

  • TURNOVER:

    GBP 28.6m (2019)

  • EBITDA:

    GBP 8.1m (2019)

  • STAFF:

    230

  • VENDOR:

    Bridges Fund Management

  • RETURNS:

    2.5x

Elysian is investing via Elysian Capital III, which closed on its GBP 325m hard-cap in 2020. Elysian III looks to invest GBP 20m-40m in UK lower-mid-market companies with enterprise values of up to GBP 100m. 

Wholebake is the second investment from the fund in quick succession, following from the acquisition of Eton Bridge Partners, a UK-based consulting firm specialising in practices covering corporate leadership.

For Bridges, the partial exit closely follows on the sale of World of Books to Livingbridge in early July. Bridges will remain invested in the company as a minority shareholder.

Bridges will reap a 2.5x return on its investment following the sale of Wholebake, in which it will also remain a minority shareholder. The firm acquired a controlling stake in the business, providing a full exit for previous backer Finance Wales, in 2014. Bridges invested via its Sustainable Growth Fund III, which closed on GBP 125m in December 2013.

At the time, Bridges said it identified Wholebake for investment as it would create at least 60 jobs during the following three to five years in an area of high unemployment in north Wales.

The investment went on to deliver in that regard, with headcount growing from 112 at the time of the investment to 230 currently. Under Bridges’ ownership, revenues also tripled, the firm said in a statement.

Previous funding
Finance Wales backed the management buyout of the business in May 2011, injecting GBP 750,000 in debt and equity. A majority shareholding was acquired from the company's founder, with the management team investing a "significant" amount, according to Unquote Data. In addition to the debt provided by Finance Wales, a leverage package was provided by an undisclosed institution for working capital. The GP first supported the firm in 2001 when its Xenos Business Angel Network provided Wholebake with an expansion investment. The fresh capital was earmarked for efficiency improvements and the implementation of new products.

Company
Founded in 1984, Wholebake is a manufacturer and distributor of gluten-free snacking products. Based in Chester and with two production facilities in north Wales, Wholebake's current portfolio includes a variety of product types including weight management, sports nutrition, toddler snacking, healthy indulgence, vegan-friendly and digestive health products.

According to publicly available accounts, Wholebake posted revenues of GBP 28.6m with operating profit of GBP 8.1m in the year to March 2020.

People
Elysian Capital - Ken Terry (partner).
Bridges Fund Management - Oliver Wyncoll (senior adviser).

Advisers
Equity - Stephenson Harwood (legal); Aon (insurance due diligence); ERM (environmental due diligence); EY (financial due diligence); BDO (tax); Spayne Lindsay (corporate finance); Food Strategy Associates (commercial due diligence).
Vendors - Grant Thornton (corporate finance, tax); EY (financial due diligence); Addleshaw Goddard (legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Exits
  • Consumer
  • UK / Ireland
  • Elysian Capital
  • Bridges Ventures
  • Secondary buyout

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013